Merck & Co., Inc. (NYSE:MRK) is walking away from nearly $7 million in taxpayer-funded state and local incentives aimed at luring to Austin a major technology innovation center operated by the pharmaceutical giant, a project once heralded as the private-sector anchor of a developing medical district around the University of Texas Dell Medical School.
insider ownership percentage is the key indicator, can be used by investors, to
measure the outlook of senior management has on their company. Insider
ownership for the MRK is 0.10%. Institutional ownership refers to the ownership
stake in a company that is held by large financial organizations, pension funds
or endowments. The Institutional ownership for the MRK is 78.00%.
Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that MRK. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Merck & Co., Inc. (NYSE:MRK) is -33.74%.
Institutional transactions is the amount of a Merck & Co., Inc. (NYSE:MRK)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the MRK is -0.69%.
A Healthcare sector firm, Merck & Co., Inc. (NYSE:MRK) stock edged up 0.90% on Tuesday and when day-trade ended the stock finally concluded at $85.51 and number of shares that changed hands during the day are 9.9 Million. The number of shares MRK stock currently held by all its shareholders are 2574.03 and floated shares, the number of shares are available for trading in an open market on last trading day are 2572.65. The average volume of shares for 3 months is 10974.83 and MRK stock value has moved between $59.8 – 86.37 in last one year.
The Merck & Co., Inc. (NYSE:MRK)’s latest earnings date is 7/30/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Merck & Co., Inc. (NYSE:MRK) is 69.10% and the profit margin is 19.50% and the stock has gained 11.91% in 2019 to date.
Merck & Co., Inc. (NYSE:MRK)’s monthly stock performance is 6.54%, the quarterly performance is 2.76%, the half year performance is calculated as 11.91%. The yearly performance of MRK is 40.87%.
The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Merck & Co., Inc. (NYSE:MRK) weekly volatility is measured as 1.76% and monthly volatility measured as 1.56%.
Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. MRK return on assets is 10.00%, the return on equity (ROE) of the Merck & Co., Inc. (NYSE:MRK) is 28.20%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and MRK return on investment is 11.70%.
The price to earnings ratio is 25.83, price to sales ratio is 5.11, and price to book ratio is 8.03, price to cash per share ration is 25.02, price to free cash flow is 72.36.
Analysts mean target price for Merck & Co., Inc. (NYSE:MRK) is $90.79 while analysts mean recommendation is 1.70. The current share price indicates that stock is -1.14% away from its one year high and is moving 42.71% ahead of its 52-week low. MRK’s distance from 20 day simple moving average is 2.37% and distance from 50-Day simple moving average is 6.29%.